| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polysaccharides, Bacterial | 157 | 2021 | 578 | 11.680 |
Why?
|
| Bacteroides fragilis | 93 | 2024 | 252 | 9.210 |
Why?
|
| Streptococcus agalactiae | 124 | 2019 | 337 | 7.880 |
Why?
|
| Bacterial Vaccines | 44 | 2019 | 401 | 3.820 |
Why?
|
| Francisella tularensis | 10 | 2019 | 62 | 3.620 |
Why?
|
| Streptococcal Infections | 58 | 2019 | 617 | 3.500 |
Why?
|
| Bacterial Capsules | 40 | 2019 | 244 | 3.340 |
Why?
|
| Intestines | 20 | 2020 | 1910 | 3.170 |
Why?
|
| Symbiosis | 21 | 2021 | 294 | 3.170 |
Why?
|
| Vaccines, Conjugate | 27 | 2019 | 328 | 3.020 |
Why?
|
| Streptococcal Vaccines | 14 | 2019 | 44 | 2.730 |
Why?
|
| Bacteroides Infections | 38 | 2012 | 89 | 2.690 |
Why?
|
| Antigens, Bacterial | 66 | 2019 | 1154 | 2.530 |
Why?
|
| Antibodies, Bacterial | 82 | 2019 | 1469 | 2.350 |
Why?
|
| Glycoconjugates | 5 | 2019 | 88 | 1.980 |
Why?
|
| Bacteria | 18 | 2023 | 2199 | 1.830 |
Why?
|
| Immune System | 10 | 2023 | 796 | 1.660 |
Why?
|
| O Antigens | 6 | 2019 | 196 | 1.600 |
Why?
|
| Gastrointestinal Tract | 6 | 2021 | 833 | 1.480 |
Why?
|
| Immunity, Maternally-Acquired | 14 | 2020 | 111 | 1.450 |
Why?
|
| Tularemia | 5 | 2019 | 42 | 1.430 |
Why?
|
| Adaptive Immunity | 7 | 2018 | 726 | 1.310 |
Why?
|
| Intestinal Mucosa | 16 | 2024 | 3032 | 1.270 |
Why?
|
| T-Lymphocytes | 36 | 2023 | 10194 | 1.220 |
Why?
|
| Toll-Like Receptor 2 | 12 | 2019 | 347 | 1.200 |
Why?
|
| Abscess | 29 | 2010 | 606 | 1.180 |
Why?
|
| Lipopolysaccharides | 23 | 2017 | 2206 | 1.170 |
Why?
|
| Carbohydrates | 9 | 2013 | 390 | 1.160 |
Why?
|
| Tetanus Toxoid | 18 | 2004 | 189 | 1.140 |
Why?
|
| Colitis | 6 | 2024 | 1233 | 1.050 |
Why?
|
| Animals | 214 | 2024 | 168475 | 1.050 |
Why?
|
| Complement C3 | 7 | 2024 | 435 | 1.020 |
Why?
|
| Mice | 122 | 2024 | 81539 | 0.980 |
Why?
|
| Glycoside Hydrolases | 6 | 2013 | 135 | 0.960 |
Why?
|
| Metagenome | 3 | 2013 | 450 | 0.920 |
Why?
|
| Immunity, Innate | 11 | 2023 | 3066 | 0.890 |
Why?
|
| Antigens, Surface | 13 | 2019 | 1606 | 0.830 |
Why?
|
| CD4-Positive T-Lymphocytes | 17 | 2023 | 4369 | 0.830 |
Why?
|
| Polysaccharides | 11 | 2020 | 1014 | 0.810 |
Why?
|
| Antigen Presentation | 8 | 2013 | 1251 | 0.810 |
Why?
|
| Histocompatibility Antigens Class II | 8 | 2011 | 1435 | 0.800 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 3 | 2020 | 152 | 0.790 |
Why?
|
| Clostridium | 4 | 2017 | 100 | 0.760 |
Why?
|
| Galactosylceramides | 1 | 2021 | 92 | 0.760 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2021 | 269 | 0.750 |
Why?
|
| Carbohydrate Sequence | 33 | 2005 | 411 | 0.740 |
Why?
|
| Virulence Factors | 3 | 2019 | 513 | 0.740 |
Why?
|
| Prevotella | 1 | 2020 | 80 | 0.730 |
Why?
|
| Lymphocytes | 5 | 2017 | 2612 | 0.730 |
Why?
|
| Bacteria, Anaerobic | 2 | 2017 | 70 | 0.700 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2020 | 32 | 0.680 |
Why?
|
| Antigen-Presenting Cells | 9 | 2011 | 964 | 0.680 |
Why?
|
| Abdominal Abscess | 9 | 2003 | 153 | 0.680 |
Why?
|
| Vaccines | 3 | 2022 | 844 | 0.670 |
Why?
|
| Germ-Free Life | 10 | 2023 | 189 | 0.670 |
Why?
|
| Bacteroides | 12 | 2010 | 165 | 0.660 |
Why?
|
| Immunity, Mucosal | 6 | 2023 | 483 | 0.650 |
Why?
|
| Bile Acids and Salts | 2 | 2024 | 393 | 0.620 |
Why?
|
| Salmonella Infections | 3 | 2017 | 172 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 43 | 2024 | 22174 | 0.610 |
Why?
|
| Natural Killer T-Cells | 4 | 2021 | 322 | 0.610 |
Why?
|
| Antibody Formation | 17 | 2018 | 1395 | 0.590 |
Why?
|
| Homeostasis | 6 | 2023 | 3323 | 0.580 |
Why?
|
| Bacterial Toxins | 10 | 2004 | 932 | 0.570 |
Why?
|
| Vaccines, Attenuated | 5 | 2011 | 315 | 0.570 |
Why?
|
| Fungi | 1 | 2020 | 338 | 0.570 |
Why?
|
| Lymphocyte Subsets | 2 | 2017 | 309 | 0.570 |
Why?
|
| Peptidoglycan | 5 | 2017 | 249 | 0.570 |
Why?
|
| Immunity, Cellular | 12 | 2008 | 1560 | 0.560 |
Why?
|
| Immunoglobulin G | 30 | 2020 | 4544 | 0.560 |
Why?
|
| Dietary Fiber | 1 | 2020 | 759 | 0.550 |
Why?
|
| Epitopes | 28 | 2018 | 2503 | 0.550 |
Why?
|
| Citrobacter rodentium | 1 | 2016 | 65 | 0.540 |
Why?
|
| Macrophages | 10 | 2017 | 5767 | 0.540 |
Why?
|
| Fatty Acids | 5 | 2023 | 1808 | 0.540 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 5 | 2021 | 823 | 0.540 |
Why?
|
| Sphingolipids | 2 | 2024 | 174 | 0.530 |
Why?
|
| Dendritic Cells | 8 | 2020 | 2747 | 0.520 |
Why?
|
| Colon | 8 | 2023 | 1792 | 0.520 |
Why?
|
| Escherichia coli Infections | 1 | 2020 | 518 | 0.510 |
Why?
|
| Mice, Inbred BALB C | 16 | 2020 | 6214 | 0.500 |
Why?
|
| Bacterial Proteins | 24 | 2010 | 3847 | 0.500 |
Why?
|
| Milk, Human | 1 | 2020 | 486 | 0.490 |
Why?
|
| Enterobacteriaceae Infections | 2 | 2016 | 188 | 0.480 |
Why?
|
| T-Lymphocytes, Regulatory | 6 | 2020 | 3080 | 0.480 |
Why?
|
| Virus Diseases | 1 | 2020 | 718 | 0.470 |
Why?
|
| HLA-DR Antigens | 3 | 2008 | 602 | 0.470 |
Why?
|
| Lymphocyte Activation | 16 | 2013 | 5485 | 0.470 |
Why?
|
| Infant, Newborn, Diseases | 7 | 2013 | 589 | 0.460 |
Why?
|
| Bacterial Infections | 7 | 2013 | 1391 | 0.460 |
Why?
|
| Cell Membrane | 13 | 2020 | 3687 | 0.460 |
Why?
|
| Lymphoid Tissue | 2 | 2013 | 445 | 0.460 |
Why?
|
| Phagocytosis | 27 | 2005 | 1528 | 0.450 |
Why?
|
| Francisella | 1 | 2013 | 6 | 0.450 |
Why?
|
| Reactive Nitrogen Species | 2 | 2010 | 34 | 0.440 |
Why?
|
| Interleukin-10 | 6 | 2017 | 1175 | 0.440 |
Why?
|
| Immunomodulation | 4 | 2021 | 549 | 0.440 |
Why?
|
| Molecular Sequence Data | 41 | 2010 | 17635 | 0.440 |
Why?
|
| Glycosphingolipids | 1 | 2014 | 73 | 0.440 |
Why?
|
| Antibodies | 6 | 2020 | 2418 | 0.440 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2013 | 30 | 0.440 |
Why?
|
| Streptococcus pneumoniae | 15 | 2009 | 730 | 0.430 |
Why?
|
| Deoxycholic Acid | 2 | 2024 | 53 | 0.430 |
Why?
|
| Carbohydrate Conformation | 24 | 2003 | 206 | 0.430 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2017 | 347 | 0.420 |
Why?
|
| Tetanus Toxin | 1 | 2012 | 46 | 0.420 |
Why?
|
| Immune Evasion | 2 | 2014 | 363 | 0.420 |
Why?
|
| Bacterial Outer Membrane Proteins | 4 | 2007 | 406 | 0.400 |
Why?
|
| Interleukin-17 | 6 | 2017 | 912 | 0.400 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2018 | 974 | 0.400 |
Why?
|
| Salmonella typhimurium | 2 | 2017 | 347 | 0.400 |
Why?
|
| Immunization | 22 | 2011 | 1227 | 0.390 |
Why?
|
| Vaccines, Synthetic | 6 | 2000 | 616 | 0.390 |
Why?
|
| Virulence | 25 | 2007 | 1303 | 0.380 |
Why?
|
| Rabbits | 41 | 2002 | 4772 | 0.370 |
Why?
|
| Ovalbumin | 1 | 2012 | 677 | 0.370 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2010 | 262 | 0.360 |
Why?
|
| Sugar Acids | 1 | 2010 | 24 | 0.360 |
Why?
|
| Inflammatory Bowel Diseases | 6 | 2016 | 2422 | 0.360 |
Why?
|
| Proteome | 1 | 2020 | 1862 | 0.360 |
Why?
|
| Clindamycin | 6 | 2004 | 139 | 0.350 |
Why?
|
| Legionella pneumophila | 1 | 2010 | 49 | 0.350 |
Why?
|
| Oligosaccharides | 8 | 2010 | 406 | 0.350 |
Why?
|
| Hexosyltransferases | 1 | 2010 | 58 | 0.350 |
Why?
|
| Toll-Like Receptor 4 | 6 | 2020 | 579 | 0.350 |
Why?
|
| Chromosome Mapping | 4 | 2016 | 4615 | 0.340 |
Why?
|
| Water | 2 | 2011 | 1411 | 0.340 |
Why?
|
| Humans | 181 | 2024 | 761596 | 0.340 |
Why?
|
| Streptococcus | 5 | 2008 | 198 | 0.330 |
Why?
|
| Opsonin Proteins | 17 | 2005 | 144 | 0.330 |
Why?
|
| Enterotoxins | 3 | 1996 | 366 | 0.330 |
Why?
|
| Mice, Knockout | 20 | 2017 | 14417 | 0.320 |
Why?
|
| Vaccination | 16 | 2022 | 3384 | 0.320 |
Why?
|
| Helicobacter hepaticus | 1 | 2008 | 25 | 0.310 |
Why?
|
| Antigens, CD1d | 3 | 2021 | 228 | 0.310 |
Why?
|
| Models, Animal | 3 | 2021 | 2112 | 0.310 |
Why?
|
| Sialic Acids | 12 | 1996 | 123 | 0.300 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2016 | 1802 | 0.300 |
Why?
|
| Cross Reactions | 11 | 2020 | 817 | 0.300 |
Why?
|
| Immune Sera | 18 | 2003 | 606 | 0.300 |
Why?
|
| Neisseria meningitidis | 9 | 2018 | 108 | 0.300 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2011 | 828 | 0.290 |
Why?
|
| Cell Separation | 2 | 2012 | 1720 | 0.290 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 2116 | 0.290 |
Why?
|
| Infant, Newborn | 25 | 2020 | 26202 | 0.290 |
Why?
|
| Animals, Newborn | 14 | 2014 | 2677 | 0.280 |
Why?
|
| Immunoglobulin A | 8 | 2020 | 978 | 0.280 |
Why?
|
| Streptococcus pyogenes | 3 | 2007 | 292 | 0.280 |
Why?
|
| Carbohydrate Metabolism | 1 | 2008 | 263 | 0.280 |
Why?
|
| Disease Models, Animal | 28 | 2024 | 18255 | 0.280 |
Why?
|
| Helicobacter pylori | 1 | 2010 | 377 | 0.280 |
Why?
|
| Reactive Oxygen Species | 3 | 2010 | 2139 | 0.280 |
Why?
|
| Genes, Bacterial | 9 | 2009 | 1073 | 0.280 |
Why?
|
| Enterocytes | 2 | 2019 | 220 | 0.280 |
Why?
|
| Serotyping | 13 | 2005 | 325 | 0.280 |
Why?
|
| Disease Susceptibility | 6 | 2021 | 1787 | 0.270 |
Why?
|
| Immunity | 2 | 2020 | 996 | 0.270 |
Why?
|
| Immunization, Passive | 11 | 1999 | 616 | 0.270 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2008 | 289 | 0.270 |
Why?
|
| Superantigens | 3 | 1996 | 126 | 0.260 |
Why?
|
| N-Acetylneuraminic Acid | 5 | 2018 | 174 | 0.260 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 19 | 2010 | 3810 | 0.260 |
Why?
|
| Androgens | 1 | 2013 | 1286 | 0.260 |
Why?
|
| Adoptive Transfer | 3 | 2014 | 819 | 0.260 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2005 | 90 | 0.250 |
Why?
|
| Autoimmunity | 1 | 2013 | 1356 | 0.250 |
Why?
|
| Rats | 35 | 2012 | 23741 | 0.250 |
Why?
|
| Host-Pathogen Interactions | 5 | 2017 | 1459 | 0.240 |
Why?
|
| Molecular Weight | 14 | 2003 | 2186 | 0.240 |
Why?
|
| Carrier Proteins | 7 | 2020 | 4937 | 0.240 |
Why?
|
| Interleukins | 2 | 2024 | 782 | 0.240 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2004 | 264 | 0.230 |
Why?
|
| Glycolipids | 2 | 2020 | 206 | 0.230 |
Why?
|
| Sepsis | 11 | 2005 | 2585 | 0.230 |
Why?
|
| Immunoglobulin M | 9 | 2008 | 1526 | 0.220 |
Why?
|
| Myeloid Differentiation Factor 88 | 5 | 2013 | 587 | 0.220 |
Why?
|
| Bacterial Load | 2 | 2016 | 152 | 0.220 |
Why?
|
| Isomerism | 1 | 2023 | 197 | 0.220 |
Why?
|
| Peritoneal Diseases | 4 | 1990 | 75 | 0.220 |
Why?
|
| Meningitis, Bacterial | 1 | 2005 | 221 | 0.220 |
Why?
|
| Female | 82 | 2020 | 392705 | 0.210 |
Why?
|
| Dextran Sulfate | 1 | 2024 | 256 | 0.210 |
Why?
|
| Models, Immunological | 4 | 2018 | 513 | 0.210 |
Why?
|
| Stress, Physiological | 1 | 2010 | 1403 | 0.210 |
Why?
|
| Prevotella melaninogenica | 6 | 1979 | 13 | 0.210 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2021 | 2547 | 0.210 |
Why?
|
| Drug Design | 1 | 2008 | 1048 | 0.210 |
Why?
|
| Neutrophils | 9 | 2024 | 3767 | 0.210 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2010 | 1693 | 0.210 |
Why?
|
| Receptors, Complement 3d | 1 | 2003 | 117 | 0.210 |
Why?
|
| Portal Vein | 1 | 2005 | 431 | 0.210 |
Why?
|
| Rats, Wistar | 10 | 2004 | 1848 | 0.200 |
Why?
|
| Linoleic Acid | 1 | 2023 | 158 | 0.200 |
Why?
|
| Phenotype | 9 | 2017 | 16592 | 0.200 |
Why?
|
| Lipolysis | 1 | 2023 | 212 | 0.200 |
Why?
|
| Antigens | 4 | 2018 | 1443 | 0.200 |
Why?
|
| Autoimmune Diseases | 2 | 2014 | 2244 | 0.200 |
Why?
|
| Signal Transduction | 9 | 2021 | 23447 | 0.200 |
Why?
|
| Anions | 1 | 2002 | 136 | 0.200 |
Why?
|
| Antibody Specificity | 10 | 2002 | 1060 | 0.190 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2012 | 221 | 0.190 |
Why?
|
| Lymph Nodes | 1 | 2013 | 3465 | 0.190 |
Why?
|
| Cations | 1 | 2002 | 238 | 0.190 |
Why?
|
| Microbial Interactions | 2 | 2013 | 74 | 0.190 |
Why?
|
| Abdomen | 9 | 1994 | 1128 | 0.180 |
Why?
|
| Vesiculovirus | 1 | 2020 | 55 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2023 | 799 | 0.180 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 11904 | 0.180 |
Why?
|
| Staphylococcus aureus | 5 | 2008 | 1457 | 0.180 |
Why?
|
| Pantoea | 1 | 2020 | 14 | 0.170 |
Why?
|
| Immunologic Factors | 1 | 2009 | 1590 | 0.170 |
Why?
|
| Bone Marrow Cells | 2 | 2020 | 2417 | 0.170 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2020 | 86 | 0.170 |
Why?
|
| Carbohydrate Dehydrogenases | 1 | 1999 | 12 | 0.170 |
Why?
|
| Antigens, CD | 9 | 2015 | 4001 | 0.170 |
Why?
|
| Gastrointestinal Diseases | 1 | 2008 | 1200 | 0.170 |
Why?
|
| Interleukin-2 | 3 | 2011 | 1889 | 0.170 |
Why?
|
| Interferon Type I | 2 | 2017 | 562 | 0.170 |
Why?
|
| Neutrophil Activation | 1 | 2020 | 180 | 0.170 |
Why?
|
| Interinstitutional Relations | 1 | 2000 | 236 | 0.170 |
Why?
|
| Clostridium Infections | 2 | 2004 | 558 | 0.170 |
Why?
|
| Immunotherapy | 4 | 2023 | 4652 | 0.170 |
Why?
|
| Goblet Cells | 1 | 2022 | 298 | 0.160 |
Why?
|
| Digestive System | 1 | 2020 | 244 | 0.160 |
Why?
|
| Male | 56 | 2020 | 360846 | 0.160 |
Why?
|
| Complement Activation | 5 | 1986 | 445 | 0.160 |
Why?
|
| Endosomes | 4 | 2009 | 522 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3415 | 0.160 |
Why?
|
| Interferon-beta | 1 | 2020 | 345 | 0.160 |
Why?
|
| Feedback, Physiological | 1 | 2021 | 476 | 0.160 |
Why?
|
| Immunologic Surveillance | 2 | 2011 | 92 | 0.160 |
Why?
|
| Demyelinating Diseases | 1 | 2021 | 352 | 0.160 |
Why?
|
| Industry | 1 | 2000 | 364 | 0.160 |
Why?
|
| Glucans | 1 | 1998 | 68 | 0.150 |
Why?
|
| B-Lymphocytes | 6 | 2010 | 4758 | 0.150 |
Why?
|
| Cell Proliferation | 5 | 2014 | 10451 | 0.150 |
Why?
|
| Stromal Cells | 1 | 2024 | 1330 | 0.150 |
Why?
|
| Meningococcal Vaccines | 1 | 2018 | 94 | 0.150 |
Why?
|
| Ruminococcus | 1 | 2017 | 11 | 0.150 |
Why?
|
| Gonorrhea | 5 | 1982 | 346 | 0.150 |
Why?
|
| Complement C1 | 4 | 1986 | 32 | 0.150 |
Why?
|
| Toll-Like Receptors | 4 | 2010 | 589 | 0.150 |
Why?
|
| Blood Bactericidal Activity | 11 | 1983 | 124 | 0.150 |
Why?
|
| Species Specificity | 6 | 2012 | 2414 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 8 | 2024 | 9177 | 0.150 |
Why?
|
| Complement Pathway, Classical | 5 | 1986 | 91 | 0.150 |
Why?
|
| Structure-Activity Relationship | 8 | 2002 | 3076 | 0.150 |
Why?
|
| Receptors, Interleukin-10 | 1 | 2017 | 50 | 0.150 |
Why?
|
| Models, Molecular | 7 | 2021 | 5439 | 0.150 |
Why?
|
| Apyrase | 3 | 2015 | 373 | 0.150 |
Why?
|
| Binding, Competitive | 7 | 2009 | 1141 | 0.150 |
Why?
|
| beta-Glucans | 1 | 1998 | 123 | 0.140 |
Why?
|
| Vaginosis, Bacterial | 1 | 2019 | 151 | 0.140 |
Why?
|
| Ions | 5 | 2004 | 256 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 8 | 2008 | 2496 | 0.140 |
Why?
|
| Membrane Glycoproteins | 9 | 2012 | 3701 | 0.140 |
Why?
|
| Oxazolone | 2 | 2014 | 61 | 0.140 |
Why?
|
| Cricetinae | 6 | 2008 | 2423 | 0.140 |
Why?
|
| Click Chemistry | 1 | 2017 | 95 | 0.140 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1996 | 35 | 0.140 |
Why?
|
| Antigenic Variation | 2 | 2001 | 118 | 0.140 |
Why?
|
| Th1 Cells | 4 | 2017 | 1036 | 0.140 |
Why?
|
| Adjuvants, Immunologic | 2 | 2001 | 1036 | 0.140 |
Why?
|
| Feces | 4 | 2019 | 1497 | 0.140 |
Why?
|
| Mice, Inbred C3H | 4 | 2006 | 915 | 0.140 |
Why?
|
| Gene Expression Regulation, Bacterial | 5 | 2010 | 1133 | 0.130 |
Why?
|
| Peritoneal Cavity | 3 | 2003 | 135 | 0.130 |
Why?
|
| Cells, Cultured | 15 | 2017 | 18966 | 0.130 |
Why?
|
| Polymers | 2 | 2003 | 1616 | 0.130 |
Why?
|
| Phylogeny | 4 | 2020 | 2811 | 0.130 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2017 | 119 | 0.130 |
Why?
|
| Receptors, Fc | 1 | 2020 | 535 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 3 | 2013 | 7406 | 0.130 |
Why?
|
| Hydroxybutyrates | 1 | 2016 | 79 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2008 | 517 | 0.130 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 1303 | 0.130 |
Why?
|
| Ozone | 1 | 1999 | 483 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1835 | 0.130 |
Why?
|
| Conflict of Interest | 1 | 2000 | 554 | 0.130 |
Why?
|
| Spleen | 5 | 2009 | 2295 | 0.130 |
Why?
|
| Colitis, Ulcerative | 4 | 2015 | 1922 | 0.130 |
Why?
|
| Cell Communication | 2 | 2004 | 1657 | 0.130 |
Why?
|
| Lysosomes | 2 | 2002 | 924 | 0.130 |
Why?
|
| Lethal Dose 50 | 3 | 2013 | 72 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 17 | 2008 | 3769 | 0.120 |
Why?
|
| Gene Deletion | 3 | 2013 | 2665 | 0.120 |
Why?
|
| Cytokines | 7 | 2017 | 7396 | 0.120 |
Why?
|
| Genome, Bacterial | 3 | 2005 | 783 | 0.120 |
Why?
|
| Genetic Complementation Test | 2 | 2010 | 555 | 0.120 |
Why?
|
| Pregnancy | 24 | 2013 | 29890 | 0.120 |
Why?
|
| Inflammation | 6 | 2020 | 10774 | 0.120 |
Why?
|
| Lipid A | 2 | 2013 | 70 | 0.120 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 999 | 0.120 |
Why?
|
| Crosses, Genetic | 1 | 2016 | 750 | 0.120 |
Why?
|
| DNA, Bacterial | 6 | 2008 | 1479 | 0.120 |
Why?
|
| Fluorescence | 1 | 2017 | 756 | 0.120 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2019 | 432 | 0.120 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 795 | 0.120 |
Why?
|
| Immunoelectrophoresis | 5 | 1995 | 94 | 0.120 |
Why?
|
| Encephalomyelitis | 1 | 2014 | 36 | 0.120 |
Why?
|
| Glycocalyx | 1 | 2015 | 97 | 0.120 |
Why?
|
| Models, Biological | 6 | 2010 | 9469 | 0.120 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2017 | 545 | 0.120 |
Why?
|
| Bacillus | 1 | 1994 | 78 | 0.120 |
Why?
|
| Adhesins, Bacterial | 2 | 2009 | 118 | 0.120 |
Why?
|
| Teichoic Acids | 3 | 2005 | 70 | 0.110 |
Why?
|
| Neisseria gonorrhoeae | 5 | 1982 | 239 | 0.110 |
Why?
|
| Schools, Medical | 1 | 2000 | 879 | 0.110 |
Why?
|
| Chromatography, Gel | 5 | 2008 | 646 | 0.110 |
Why?
|
| Staining and Labeling | 2 | 2017 | 1085 | 0.110 |
Why?
|
| Flow Cytometry | 5 | 2018 | 5870 | 0.110 |
Why?
|
| Amino Acid Motifs | 3 | 2005 | 931 | 0.110 |
Why?
|
| Peritonitis | 2 | 2015 | 368 | 0.110 |
Why?
|
| Protein Binding | 5 | 2024 | 9353 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 6 | 1997 | 783 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2011 | 1844 | 0.110 |
Why?
|
| Th17 Cells | 2 | 2016 | 794 | 0.110 |
Why?
|
| Macrophages, Peritoneal | 2 | 2005 | 238 | 0.110 |
Why?
|
| Salmonella enterica | 1 | 2013 | 76 | 0.110 |
Why?
|
| Sequence Deletion | 2 | 2001 | 1494 | 0.110 |
Why?
|
| Immunodiffusion | 7 | 1989 | 141 | 0.100 |
Why?
|
| Antigen-Antibody Reactions | 6 | 1987 | 340 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 10 | 1991 | 2467 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 4580 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2012 | 4352 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 789 | 0.100 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2019 | 803 | 0.100 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1997 | 664 | 0.100 |
Why?
|
| Escherichia coli Proteins | 1 | 1999 | 1067 | 0.100 |
Why?
|
| Yin-Yang | 1 | 2012 | 10 | 0.100 |
Why?
|
| Mesentery | 1 | 2013 | 202 | 0.100 |
Why?
|
| Lymphocyte Depletion | 1 | 2014 | 602 | 0.100 |
Why?
|
| Animal Structures | 1 | 2011 | 24 | 0.100 |
Why?
|
| Lung | 3 | 2020 | 10002 | 0.100 |
Why?
|
| Genetic Variation | 4 | 2005 | 6567 | 0.100 |
Why?
|
| Perinatology | 1 | 1991 | 63 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 1668 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2020 | 1360 | 0.090 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 1996 | 536 | 0.090 |
Why?
|
| Mutation | 6 | 2010 | 30053 | 0.090 |
Why?
|
| Viral Load | 1 | 2020 | 3332 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 1998 | 1359 | 0.090 |
Why?
|
| Microscopy, Electron | 10 | 1989 | 2561 | 0.090 |
Why?
|
| CHO Cells | 4 | 2008 | 1387 | 0.090 |
Why?
|
| Macrophage Activation | 2 | 2005 | 553 | 0.090 |
Why?
|
| Probiotics | 2 | 2016 | 378 | 0.090 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 755 | 0.090 |
Why?
|
| Molecular Mimicry | 2 | 2014 | 213 | 0.090 |
Why?
|
| Mitogens | 2 | 1999 | 230 | 0.090 |
Why?
|
| Colorectal Surgery | 1 | 2012 | 122 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 10 | 1991 | 1741 | 0.090 |
Why?
|
| Guinea Pigs | 4 | 2004 | 1310 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2013 | 10090 | 0.090 |
Why?
|
| Guanosine Tetraphosphate | 1 | 2009 | 11 | 0.090 |
Why?
|
| Biocatalysis | 1 | 2010 | 170 | 0.090 |
Why?
|
| Receptors, Chemokine | 1 | 2013 | 652 | 0.090 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 253 | 0.080 |
Why?
|
| Mucous Membrane | 1 | 2013 | 659 | 0.080 |
Why?
|
| Oxidation-Reduction | 4 | 2010 | 2231 | 0.080 |
Why?
|
| Microbial Viability | 1 | 2011 | 238 | 0.080 |
Why?
|
| Immunoblotting | 4 | 1995 | 1646 | 0.080 |
Why?
|
| Host-Parasite Interactions | 1 | 2012 | 300 | 0.080 |
Why?
|
| Cell Line | 4 | 2019 | 15601 | 0.080 |
Why?
|
| Colorectal Neoplasms | 2 | 2024 | 6938 | 0.080 |
Why?
|
| Helicobacter | 1 | 2009 | 111 | 0.080 |
Why?
|
| Th2 Cells | 2 | 2017 | 1060 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2273 | 0.080 |
Why?
|
| Plants | 1 | 2010 | 327 | 0.080 |
Why?
|
| Mothers | 1 | 2020 | 2198 | 0.080 |
Why?
|
| Cell Count | 1 | 2013 | 1835 | 0.080 |
Why?
|
| Mucus | 2 | 2022 | 341 | 0.080 |
Why?
|
| Nitric Oxide | 2 | 2009 | 2136 | 0.080 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 4 | 2001 | 353 | 0.080 |
Why?
|
| Injections, Intradermal | 1 | 2008 | 116 | 0.080 |
Why?
|
| Chemokines, CXC | 2 | 2008 | 422 | 0.080 |
Why?
|
| Immune Tolerance | 2 | 2016 | 2302 | 0.080 |
Why?
|
| Carrageenan | 1 | 1988 | 71 | 0.080 |
Why?
|
| Hyperthermia, Induced | 1 | 2012 | 417 | 0.080 |
Why?
|
| Molecular Structure | 7 | 1995 | 1880 | 0.080 |
Why?
|
| Amino Acids | 4 | 2010 | 1718 | 0.080 |
Why?
|
| Salts | 1 | 2008 | 63 | 0.080 |
Why?
|
| Cell Survival | 2 | 2017 | 5791 | 0.080 |
Why?
|
| HLA-D Antigens | 1 | 2008 | 129 | 0.080 |
Why?
|
| Base Sequence | 8 | 2005 | 12441 | 0.080 |
Why?
|
| Enterococcus faecium | 2 | 1999 | 101 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 5305 | 0.070 |
Why?
|
| Sensory Receptor Cells | 1 | 2013 | 513 | 0.070 |
Why?
|
| Receptors, Cell Surface | 5 | 2005 | 2822 | 0.070 |
Why?
|
| Interleukin-4 | 1 | 2011 | 1149 | 0.070 |
Why?
|
| Escherichia coli | 6 | 2013 | 4217 | 0.070 |
Why?
|
| Mannose-Binding Lectin | 1 | 2008 | 145 | 0.070 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2010 | 495 | 0.070 |
Why?
|
| Enterococcus faecalis | 2 | 1999 | 245 | 0.070 |
Why?
|
| Cell Wall | 8 | 2000 | 425 | 0.070 |
Why?
|
| Complement System Proteins | 9 | 1986 | 735 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 4 | 2015 | 1616 | 0.070 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2011 | 1936 | 0.070 |
Why?
|
| Bacteroidetes | 2 | 2019 | 84 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1903 | 0.070 |
Why?
|
| Rats, Inbred Lew | 4 | 2004 | 1157 | 0.070 |
Why?
|
| Hexuronic Acids | 2 | 1984 | 145 | 0.070 |
Why?
|
| Body Weight | 1 | 2017 | 4618 | 0.070 |
Why?
|
| Epithelial Cells | 3 | 2019 | 3677 | 0.070 |
Why?
|
| Mesocricetus | 2 | 2004 | 252 | 0.070 |
Why?
|
| Cricetulus | 1 | 2008 | 814 | 0.070 |
Why?
|
| Papio | 2 | 2000 | 669 | 0.070 |
Why?
|
| Bacterial Adhesion | 2 | 2005 | 306 | 0.070 |
Why?
|
| History, 20th Century | 4 | 2004 | 2767 | 0.060 |
Why?
|
| Vancomycin | 2 | 1999 | 503 | 0.060 |
Why?
|
| Proteins | 2 | 2001 | 6032 | 0.060 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2022 | 323 | 0.060 |
Why?
|
| Transcription Factor RelA | 1 | 2006 | 254 | 0.060 |
Why?
|
| Receptors, Complement | 1 | 1986 | 253 | 0.060 |
Why?
|
| Respiratory Burst | 1 | 2005 | 110 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2009 | 6131 | 0.060 |
Why?
|
| Amino Acid Sequence | 6 | 2010 | 13446 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 3 | 2024 | 4415 | 0.060 |
Why?
|
| Antibody Affinity | 3 | 2002 | 246 | 0.060 |
Why?
|
| Fever of Unknown Origin | 1 | 2005 | 94 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2019 | 696 | 0.060 |
Why?
|
| Legionella | 2 | 1982 | 27 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2000 | 3429 | 0.060 |
Why?
|
| Anorexia | 1 | 2005 | 154 | 0.060 |
Why?
|
| Thrombophlebitis | 1 | 2005 | 289 | 0.060 |
Why?
|
| Pelvic Inflammatory Disease | 3 | 1981 | 96 | 0.060 |
Why?
|
| Complement Pathway, Alternative | 3 | 1985 | 113 | 0.060 |
Why?
|
| Appendix | 1 | 2005 | 109 | 0.060 |
Why?
|
| Sweating | 1 | 2005 | 155 | 0.060 |
Why?
|
| Glycoproteins | 2 | 1995 | 2203 | 0.060 |
Why?
|
| Sequence Analysis | 3 | 2000 | 240 | 0.060 |
Why?
|
| Melanoma | 1 | 2023 | 5709 | 0.060 |
Why?
|
| Hematologic Tests | 1 | 2005 | 239 | 0.060 |
Why?
|
| Endotoxins | 4 | 1982 | 520 | 0.060 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2004 | 94 | 0.060 |
Why?
|
| Macaca mulatta | 2 | 2008 | 2329 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 1827 | 0.060 |
Why?
|
| Adult | 32 | 2019 | 221210 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2000 | 6075 | 0.060 |
Why?
|
| Yersinia enterocolitica | 1 | 1983 | 13 | 0.050 |
Why?
|
| Blood Chemical Analysis | 1 | 2005 | 437 | 0.050 |
Why?
|
| Health | 1 | 2006 | 398 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 9542 | 0.050 |
Why?
|
| Clonal Anergy | 1 | 2004 | 169 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2012 | 2242 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1994 | 2688 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8181 | 0.050 |
Why?
|
| Meningitis | 4 | 1981 | 217 | 0.050 |
Why?
|
| Hypertension, Portal | 1 | 2005 | 226 | 0.050 |
Why?
|
| Anaerobiosis | 2 | 2019 | 138 | 0.050 |
Why?
|
| Receptor Activity-Modifying Protein 1 | 1 | 2022 | 18 | 0.050 |
Why?
|
| Cyclobutanes | 1 | 2003 | 57 | 0.050 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2003 | 50 | 0.050 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 1699 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 4 | 2007 | 4740 | 0.050 |
Why?
|
| Endocytosis | 2 | 2004 | 957 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 5 | 1987 | 510 | 0.050 |
Why?
|
| CD40 Ligand | 2 | 2005 | 522 | 0.050 |
Why?
|
| Cecum | 2 | 2002 | 233 | 0.050 |
Why?
|
| Ligands | 2 | 2024 | 3272 | 0.050 |
Why?
|
| Plasmids | 4 | 2005 | 2269 | 0.050 |
Why?
|
| Alum Compounds | 1 | 2001 | 32 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2002 | 384 | 0.050 |
Why?
|
| Lymphokines | 1 | 1985 | 927 | 0.050 |
Why?
|
| Glycosylation | 1 | 2005 | 1097 | 0.050 |
Why?
|
| Tissue Adhesions | 2 | 2002 | 218 | 0.050 |
Why?
|
| Multigene Family | 2 | 2005 | 1076 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2023 | 263 | 0.050 |
Why?
|
| Vagina | 4 | 1999 | 838 | 0.050 |
Why?
|
| Maternal-Fetal Exchange | 3 | 1981 | 461 | 0.050 |
Why?
|
| Cholesterol | 1 | 2010 | 2905 | 0.050 |
Why?
|
| Liver | 2 | 2008 | 7528 | 0.050 |
Why?
|
| Insulin | 1 | 2016 | 6597 | 0.050 |
Why?
|
| Binding Sites, Antibody | 4 | 1989 | 337 | 0.050 |
Why?
|
| Cloning, Molecular | 5 | 2001 | 4174 | 0.050 |
Why?
|
| Osteopetrosis | 1 | 2001 | 43 | 0.050 |
Why?
|
| Technology Transfer | 1 | 2000 | 42 | 0.050 |
Why?
|
| Pancreatitis | 1 | 1988 | 1096 | 0.050 |
Why?
|
| Fetus | 2 | 2019 | 1863 | 0.050 |
Why?
|
| Smallpox | 1 | 2000 | 43 | 0.050 |
Why?
|
| Haemophilus Infections | 1 | 1980 | 94 | 0.040 |
Why?
|
| Kinetics | 6 | 2003 | 6374 | 0.040 |
Why?
|
| History, 18th Century | 1 | 2000 | 207 | 0.040 |
Why?
|
| Buffers | 1 | 2000 | 146 | 0.040 |
Why?
|
| Bacteremia | 2 | 1998 | 980 | 0.040 |
Why?
|
| Haemophilus influenzae | 1 | 1980 | 178 | 0.040 |
Why?
|
| Receptors, Immunologic | 2 | 2005 | 1410 | 0.040 |
Why?
|
| Germinal Center | 1 | 2003 | 380 | 0.040 |
Why?
|
| Carbohydrate Epimerases | 1 | 1999 | 46 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2024 | 871 | 0.040 |
Why?
|
| Chemokine CXCL5 | 1 | 2019 | 27 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2008 | 3162 | 0.040 |
Why?
|
| Chloride Channels | 1 | 2001 | 221 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2002 | 909 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2000 | 364 | 0.040 |
Why?
|
| Mice, Inbred CBA | 1 | 2020 | 436 | 0.040 |
Why?
|
| Gram-Negative Anaerobic Bacteria | 1 | 1979 | 15 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 1998 | 1762 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2001 | 405 | 0.040 |
Why?
|
| Surgical Wound Infection | 2 | 2008 | 1529 | 0.040 |
Why?
|
| Thyrotropin | 1 | 1983 | 834 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 1999 | 6534 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2000 | 174 | 0.040 |
Why?
|
| Multiple Sclerosis | 2 | 2014 | 3222 | 0.040 |
Why?
|
| Empyema | 1 | 1979 | 41 | 0.040 |
Why?
|
| Immunologic Techniques | 4 | 1983 | 212 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 1407 | 0.040 |
Why?
|
| Legionnaires' Disease | 1 | 1979 | 49 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 1999 | 364 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 1999 | 413 | 0.040 |
Why?
|
| Serum Albumin | 1 | 2002 | 672 | 0.040 |
Why?
|
| Arabidopsis Proteins | 1 | 2000 | 264 | 0.040 |
Why?
|
| Gene Expression | 3 | 2006 | 7581 | 0.040 |
Why?
|
| Nociceptors | 1 | 2022 | 461 | 0.040 |
Why?
|
| Appendicitis | 1 | 2005 | 675 | 0.040 |
Why?
|
| Solutions | 1 | 1999 | 412 | 0.040 |
Why?
|
| Precipitin Tests | 4 | 1991 | 813 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2023 | 2919 | 0.040 |
Why?
|
| Technology | 1 | 2021 | 292 | 0.040 |
Why?
|
| Diet | 1 | 2016 | 8075 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 364 | 0.040 |
Why?
|
| DNA Transposable Elements | 4 | 1991 | 755 | 0.040 |
Why?
|
| Fibrosis | 1 | 2005 | 2049 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2001 | 376 | 0.040 |
Why?
|
| Colony Count, Microbial | 2 | 2008 | 330 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2000 | 432 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2006 | 2898 | 0.040 |
Why?
|
| History, 19th Century | 1 | 2000 | 720 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 2748 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2000 | 370 | 0.040 |
Why?
|
| Otitis Media | 1 | 1980 | 286 | 0.040 |
Why?
|
| Methylation | 5 | 1991 | 1084 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2010 | 2279 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3549 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 1991 | 2947 | 0.040 |
Why?
|
| Bone Development | 1 | 2001 | 472 | 0.040 |
Why?
|
| Adolescent | 11 | 2004 | 88326 | 0.040 |
Why?
|
| Solubility | 1 | 1999 | 1091 | 0.040 |
Why?
|
| Wound Infection | 2 | 1979 | 246 | 0.040 |
Why?
|
| Microglia | 1 | 2006 | 1362 | 0.040 |
Why?
|
| Immunity, Active | 2 | 1989 | 58 | 0.040 |
Why?
|
| Asthma | 2 | 2016 | 6234 | 0.040 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 1088 | 0.030 |
Why?
|
| Osteoclasts | 1 | 2001 | 711 | 0.030 |
Why?
|
| Restriction Mapping | 2 | 1994 | 851 | 0.030 |
Why?
|
| Adsorption | 3 | 2001 | 197 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 58984 | 0.030 |
Why?
|
| Immunochemistry | 2 | 1991 | 116 | 0.030 |
Why?
|
| Cathepsin D | 1 | 1996 | 59 | 0.030 |
Why?
|
| Dimerization | 1 | 1998 | 891 | 0.030 |
Why?
|
| Immunoassay | 4 | 1988 | 745 | 0.030 |
Why?
|
| Middle Aged | 10 | 2020 | 220921 | 0.030 |
Why?
|
| Biodiversity | 1 | 2019 | 347 | 0.030 |
Why?
|
| Transfection | 3 | 2001 | 5774 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 1989 | 445 | 0.030 |
Why?
|
| Endopeptidases | 3 | 2000 | 774 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 1999 | 815 | 0.030 |
Why?
|
| Bacteriological Techniques | 3 | 2010 | 275 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 1998 | 552 | 0.030 |
Why?
|
| Immunophenotyping | 2 | 2015 | 1869 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1996 | 767 | 0.030 |
Why?
|
| Galactose | 5 | 1995 | 297 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 1998 | 635 | 0.030 |
Why?
|
| Amino Sugars | 3 | 1984 | 39 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 1998 | 687 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1996 | 866 | 0.030 |
Why?
|
| Brain | 2 | 2021 | 27121 | 0.030 |
Why?
|
| Transformation, Bacterial | 1 | 1994 | 76 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1612 | 0.030 |
Why?
|
| Electrochemistry | 1 | 1994 | 145 | 0.030 |
Why?
|
| Mice, Nude | 2 | 1999 | 3614 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 1994 | 344 | 0.030 |
Why?
|
| Arthritis, Experimental | 1 | 2016 | 291 | 0.030 |
Why?
|
| Disease Progression | 1 | 2011 | 13510 | 0.030 |
Why?
|
| Radiography | 1 | 2005 | 6965 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2005 | 15633 | 0.030 |
Why?
|
| Neuraminidase | 4 | 1992 | 196 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 1994 | 192 | 0.030 |
Why?
|
| Safety | 1 | 1999 | 1149 | 0.030 |
Why?
|
| Toll-Like Receptor 6 | 2 | 2005 | 29 | 0.030 |
Why?
|
| Trypsin | 1 | 1994 | 495 | 0.030 |
Why?
|
| Weight Loss | 1 | 2005 | 2684 | 0.030 |
Why?
|
| Chromatography | 2 | 1972 | 189 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 1995 | 227 | 0.030 |
Why?
|
| Obesity | 1 | 2016 | 12947 | 0.030 |
Why?
|
| Mutagenesis | 3 | 2005 | 1232 | 0.030 |
Why?
|
| Meningitis, Meningococcal | 1 | 1973 | 43 | 0.030 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2017 | 326 | 0.030 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 1 | 2013 | 45 | 0.030 |
Why?
|
| Isoelectric Focusing | 1 | 1992 | 150 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1996 | 1351 | 0.030 |
Why?
|
| Hypothalamus | 1 | 1998 | 999 | 0.030 |
Why?
|
| Infant | 9 | 1999 | 36193 | 0.030 |
Why?
|
| Carbon Isotopes | 5 | 1973 | 458 | 0.030 |
Why?
|
| Chemokine CXCL6 | 1 | 2012 | 14 | 0.030 |
Why?
|
| Chemical Precipitation | 2 | 1985 | 175 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1992 | 317 | 0.030 |
Why?
|
| Salmonella typhi | 1 | 1993 | 198 | 0.020 |
Why?
|
| Receptors, CXCR | 1 | 2012 | 52 | 0.020 |
Why?
|
| Leukocytes | 1 | 1980 | 2026 | 0.020 |
Why?
|
| Peptides | 2 | 2004 | 4358 | 0.020 |
Why?
|
| Reference Standards | 1 | 1995 | 1003 | 0.020 |
Why?
|
| Biological Transport | 1 | 1996 | 2091 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2002 | 6815 | 0.020 |
Why?
|
| Blotting, Western | 3 | 2001 | 5035 | 0.020 |
Why?
|
| DNA Primers | 1 | 1996 | 2820 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 1841 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 3 | 2010 | 5790 | 0.020 |
Why?
|
| Immunotoxins | 1 | 1992 | 175 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 2012 | 250 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1991 | 297 | 0.020 |
Why?
|
| Calcitonin | 1 | 2012 | 329 | 0.020 |
Why?
|
| Dissection | 1 | 2013 | 298 | 0.020 |
Why?
|
| Aged | 4 | 2020 | 169310 | 0.020 |
Why?
|
| Hexoses | 3 | 1984 | 29 | 0.020 |
Why?
|
| Radioimmunoassay | 4 | 1984 | 861 | 0.020 |
Why?
|
| Rhamnose | 3 | 1995 | 18 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2013 | 927 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 4 | 1973 | 85 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 1 | 1991 | 281 | 0.020 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1989 | 49 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 12973 | 0.020 |
Why?
|
| Micropore Filters | 1 | 1989 | 22 | 0.020 |
Why?
|
| Integrin alpha Chains | 1 | 2010 | 95 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2004 | 12341 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2000 | 3113 | 0.020 |
Why?
|
| Point Mutation | 1 | 1994 | 1595 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1989 | 201 | 0.020 |
Why?
|
| HMGB1 Protein | 1 | 2010 | 137 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1996 | 1352 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2012 | 1574 | 0.020 |
Why?
|
| Penicillins | 1 | 1991 | 402 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 795 | 0.020 |
Why?
|
| Complement C2 | 3 | 1982 | 46 | 0.020 |
Why?
|
| Peritoneal Dialysis | 1 | 1989 | 159 | 0.020 |
Why?
|
| Glucosamine | 3 | 1978 | 128 | 0.020 |
Why?
|
| RNA Interference | 1 | 2017 | 2832 | 0.020 |
Why?
|
| beta-Galactosidase | 2 | 1990 | 574 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2012 | 1132 | 0.020 |
Why?
|
| Epithelium | 1 | 2013 | 1603 | 0.020 |
Why?
|
| Glucose | 6 | 1995 | 4347 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1302 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 3612 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1997 | 3396 | 0.020 |
Why?
|
| Prognosis | 1 | 2008 | 29629 | 0.020 |
Why?
|
| Hemagglutination Tests | 5 | 1973 | 76 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2000 | 12794 | 0.020 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2008 | 141 | 0.020 |
Why?
|
| United States | 4 | 2007 | 72340 | 0.020 |
Why?
|
| Optical Rotation | 1 | 1987 | 12 | 0.020 |
Why?
|
| Oxygen | 1 | 2019 | 4227 | 0.020 |
Why?
|
| Uronic Acids | 2 | 1984 | 16 | 0.020 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2009 | 367 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 455 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 7593 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 1987 | 213 | 0.020 |
Why?
|
| Recombination, Genetic | 2 | 2005 | 1519 | 0.020 |
Why?
|
| Carrier State | 3 | 1981 | 523 | 0.020 |
Why?
|
| Pharynx | 2 | 1980 | 432 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2012 | 1328 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2016 | 1171 | 0.020 |
Why?
|
| Colorimetry | 1 | 1987 | 150 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1987 | 1058 | 0.020 |
Why?
|
| Birds | 1 | 1987 | 168 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2009 | 517 | 0.020 |
Why?
|
| Complement C1 Inactivator Proteins | 1 | 1986 | 89 | 0.020 |
Why?
|
| Fever | 2 | 2012 | 1618 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1988 | 583 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 2 | 1999 | 825 | 0.020 |
Why?
|
| Sheep | 2 | 1986 | 1440 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1991 | 1440 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1996 | 4142 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 2 | 1979 | 321 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2008 | 390 | 0.020 |
Why?
|
| Chromatography, Gas | 2 | 1987 | 151 | 0.020 |
Why?
|
| Insect Proteins | 1 | 1987 | 254 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1989 | 1596 | 0.020 |
Why?
|
| Suppressor Factors, Immunologic | 1 | 1985 | 68 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1982 | 7859 | 0.020 |
Why?
|
| NF-kappa B | 2 | 2005 | 2490 | 0.020 |
Why?
|
| Action Potentials | 1 | 2013 | 1834 | 0.020 |
Why?
|
| Phosphatidic Acids | 1 | 1985 | 49 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 1161 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9420 | 0.010 |
Why?
|
| Inflammation Mediators | 2 | 2005 | 1886 | 0.010 |
Why?
|
| Drug Stability | 1 | 1985 | 291 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2005 | 145 | 0.010 |
Why?
|
| Puerperal Infection | 2 | 1981 | 44 | 0.010 |
Why?
|
| Acetylglucosamine | 2 | 1995 | 189 | 0.010 |
Why?
|
| Hemolysis | 1 | 1986 | 415 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 1990 | 2151 | 0.010 |
Why?
|
| Receptors, Thyrotropin | 1 | 1983 | 45 | 0.010 |
Why?
|
| STAT4 Transcription Factor | 1 | 2003 | 93 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4576 | 0.010 |
Why?
|
| Aging | 2 | 2012 | 8710 | 0.010 |
Why?
|
| Hydrolysis | 2 | 1988 | 664 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 1984 | 434 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1987 | 1248 | 0.010 |
Why?
|
| Metronidazole | 2 | 1982 | 232 | 0.010 |
Why?
|
| Absorption | 2 | 1979 | 242 | 0.010 |
Why?
|
| Monosaccharides | 1 | 1983 | 68 | 0.010 |
Why?
|
| Hybridomas | 1 | 2004 | 442 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 2003 | 194 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1984 | 2088 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 1982 | 40 | 0.010 |
Why?
|
| Alanine | 1 | 2005 | 609 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 201 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3208 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2001 | 3733 | 0.010 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2002 | 58 | 0.010 |
Why?
|
| Antibody-Producing Cells | 1 | 1982 | 140 | 0.010 |
Why?
|
| Biological Assay | 1 | 1985 | 626 | 0.010 |
Why?
|
| Oligodendroglia | 1 | 2006 | 538 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2013 | 2009 | 0.010 |
Why?
|
| Lymphocyte Antigen 96 | 1 | 2001 | 21 | 0.010 |
Why?
|
| Static Electricity | 1 | 2002 | 261 | 0.010 |
Why?
|
| Kanamycin | 1 | 1982 | 63 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2010 | 4021 | 0.010 |
Why?
|
| Heptoses | 3 | 1976 | 8 | 0.010 |
Why?
|
| Macaca | 1 | 1983 | 410 | 0.010 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2001 | 48 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2016 | 3964 | 0.010 |
Why?
|
| Binding Sites | 2 | 1983 | 6056 | 0.010 |
Why?
|
| Phagocytes | 1 | 1983 | 295 | 0.010 |
Why?
|
| Genotype | 1 | 1996 | 12990 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2008 | 64685 | 0.010 |
Why?
|
| Chromosome Inversion | 1 | 2001 | 120 | 0.010 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2002 | 233 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 2180 | 0.010 |
Why?
|
| Age Factors | 3 | 2016 | 18399 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2002 | 595 | 0.010 |
Why?
|
| Consumer Product Safety | 1 | 2001 | 122 | 0.010 |
Why?
|
| Peritoneum | 2 | 1982 | 225 | 0.010 |
Why?
|
| Protein Folding | 1 | 2005 | 870 | 0.010 |
Why?
|
| Cell Surface Extensions | 1 | 2001 | 67 | 0.010 |
Why?
|
| Chemical Fractionation | 1 | 1980 | 61 | 0.010 |
Why?
|
| Cell Death | 1 | 2006 | 1679 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 4948 | 0.010 |
Why?
|
| Tyrosine | 1 | 2005 | 1440 | 0.010 |
Why?
|
| Biological Factors | 1 | 2001 | 157 | 0.010 |
Why?
|
| Splenectomy | 1 | 1982 | 391 | 0.010 |
Why?
|
| Integrin beta3 | 1 | 2001 | 120 | 0.010 |
Why?
|
| Fetal Blood | 3 | 1982 | 1347 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1996 | 14665 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2000 | 317 | 0.010 |
Why?
|
| Acetylglucosaminidase | 1 | 2000 | 66 | 0.010 |
Why?
|
| Precipitins | 1 | 1979 | 4 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1980 | 352 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 460 | 0.010 |
Why?
|
| Biopolymers | 1 | 2001 | 184 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2001 | 284 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2002 | 509 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 59260 | 0.010 |
Why?
|
| Ferritins | 2 | 1982 | 598 | 0.010 |
Why?
|
| Goats | 1 | 1979 | 165 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 1979 | 149 | 0.010 |
Why?
|
| Time Factors | 7 | 1984 | 39969 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15843 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2001 | 562 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2008 | 16990 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 4125 | 0.010 |
Why?
|
| Vulvitis | 1 | 1979 | 8 | 0.010 |
Why?
|
| Subphrenic Abscess | 1 | 1979 | 22 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2001 | 305 | 0.010 |
Why?
|
| Leg Dermatoses | 1 | 1979 | 20 | 0.010 |
Why?
|
| Ruthenium Red | 1 | 1978 | 19 | 0.010 |
Why?
|
| Pneumococcal Infections | 1 | 2004 | 501 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 1545 | 0.010 |
Why?
|
| Endometritis | 1 | 1979 | 49 | 0.010 |
Why?
|
| Immunization, Secondary | 1 | 2001 | 367 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2000 | 8601 | 0.010 |
Why?
|
| Membranes | 1 | 1979 | 165 | 0.010 |
Why?
|
| Organelles | 1 | 2001 | 266 | 0.010 |
Why?
|
| Exotoxins | 1 | 1979 | 121 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1978 | 154 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1979 | 251 | 0.010 |
Why?
|
| Genital Diseases, Female | 1 | 1980 | 192 | 0.010 |
Why?
|
| Caprylates | 1 | 1979 | 115 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1978 | 507 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 1979 | 145 | 0.010 |
Why?
|
| Astrocytes | 1 | 2006 | 1346 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2000 | 731 | 0.010 |
Why?
|
| Dermatitis | 1 | 1980 | 202 | 0.010 |
Why?
|
| Pyramidal Cells | 1 | 2000 | 369 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1978 | 276 | 0.010 |
Why?
|
| Culture Media | 2 | 1980 | 897 | 0.010 |
Why?
|
| Isoantibodies | 1 | 1981 | 674 | 0.010 |
Why?
|
| Clostridium perfringens | 2 | 1979 | 29 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1981 | 852 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2012 | 4399 | 0.010 |
Why?
|
| Apoptosis | 2 | 2006 | 9490 | 0.010 |
Why?
|
| Haplorhini | 1 | 1978 | 525 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1997 | 223 | 0.010 |
Why?
|
| Optic Nerve | 1 | 2001 | 572 | 0.010 |
Why?
|
| Epididymitis | 1 | 1977 | 37 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1979 | 563 | 0.010 |
Why?
|
| Bone Resorption | 1 | 2001 | 723 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 1900 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2001 | 910 | 0.010 |
Why?
|
| Shwartzman Phenomenon | 1 | 1976 | 9 | 0.010 |
Why?
|
| Chick Embryo | 2 | 1976 | 982 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1529 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1986 | 2413 | 0.010 |
Why?
|
| Convalescence | 1 | 1977 | 105 | 0.010 |
Why?
|
| Arachnoid | 1 | 1976 | 50 | 0.010 |
Why?
|
| Retinal Degeneration | 1 | 2001 | 413 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2002 | 1071 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2001 | 836 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2001 | 1510 | 0.010 |
Why?
|
| Arthritis, Infectious | 1 | 1980 | 347 | 0.010 |
Why?
|
| Chromatography, Paper | 1 | 1976 | 76 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 2001 | 748 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1998 | 618 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2016 | 12130 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1976 | 141 | 0.010 |
Why?
|
| Enterobacter | 1 | 1995 | 44 | 0.010 |
Why?
|
| Skin Tests | 1 | 1978 | 637 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2000 | 1968 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22176 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2003 | 9610 | 0.010 |
Why?
|
| Burns | 1 | 1987 | 1882 | 0.010 |
Why?
|
| Protein Transport | 1 | 2001 | 1967 | 0.010 |
Why?
|
| Fucose | 1 | 1995 | 122 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2001 | 1674 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 1971 | 0.010 |
Why?
|
| Hysterectomy | 1 | 1980 | 857 | 0.010 |
Why?
|
| Periodontitis | 1 | 1979 | 568 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2000 | 1134 | 0.010 |
Why?
|
| Blood | 1 | 1977 | 596 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1998 | 1126 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3792 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 551 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 3779 | 0.010 |
Why?
|
| Abdominal Injuries | 1 | 1977 | 360 | 0.010 |
Why?
|
| Cattle | 1 | 1979 | 3849 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4853 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1991 | 5146 | 0.010 |
Why?
|
| Autoanalysis | 1 | 1973 | 71 | 0.010 |
Why?
|
| Antigens, Ly | 2 | 1986 | 295 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 2856 | 0.010 |
Why?
|
| Hexosamines | 1 | 1973 | 40 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1979 | 1866 | 0.010 |
Why?
|
| Computational Biology | 1 | 2005 | 3517 | 0.010 |
Why?
|
| TATA Box | 1 | 1992 | 127 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11530 | 0.010 |
Why?
|
| Research Design | 1 | 1988 | 6180 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1992 | 279 | 0.010 |
Why?
|
| Immunotherapy, Active | 1 | 1992 | 59 | 0.010 |
Why?
|
| Methods | 1 | 1972 | 1067 | 0.010 |
Why?
|
| Communicable Diseases | 2 | 1990 | 875 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1972 | 531 | 0.010 |
Why?
|
| Filtration | 1 | 1972 | 228 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 4465 | 0.010 |
Why?
|
| Acute Disease | 2 | 1981 | 7237 | 0.010 |
Why?
|
| Autoradiography | 1 | 1972 | 728 | 0.010 |
Why?
|
| RNA | 1 | 2001 | 2725 | 0.010 |
Why?
|
| Cell Movement | 1 | 2003 | 5205 | 0.010 |
Why?
|
| Acrylamides | 1 | 1972 | 260 | 0.010 |
Why?
|
| Meningococcal Infections | 1 | 1971 | 77 | 0.010 |
Why?
|
| Dextrans | 1 | 1972 | 574 | 0.010 |
Why?
|
| Hemolysin Proteins | 1 | 1990 | 113 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1991 | 462 | 0.010 |
Why?
|
| Peptide Fragments | 2 | 1997 | 5112 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1998 | 1819 | 0.010 |
Why?
|
| Retina | 1 | 2001 | 2659 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1990 | 777 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10766 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2002 | 6241 | 0.010 |
Why?
|
| Periodicals as Topic | 2 | 1990 | 1463 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2013 | 54423 | 0.000 |
Why?
|
| Enterobacteriaceae | 2 | 1981 | 161 | 0.000 |
Why?
|
| Societies, Medical | 2 | 1990 | 3905 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11076 | 0.000 |
Why?
|
| Amyloid beta-Peptides | 1 | 2000 | 3839 | 0.000 |
Why?
|
| Latex Fixation Tests | 2 | 1979 | 29 | 0.000 |
Why?
|
| Neurons | 1 | 2006 | 9463 | 0.000 |
Why?
|
| Clone Cells | 1 | 1990 | 1659 | 0.000 |
Why?
|
| Lipids | 1 | 1978 | 3341 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1977 | 3156 | 0.000 |
Why?
|
| Glioma | 1 | 2000 | 3455 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1997 | 3575 | 0.000 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1984 | 33 | 0.000 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1984 | 52 | 0.000 |
Why?
|
| Risk Factors | 1 | 1991 | 74213 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1977 | 2492 | 0.000 |
Why?
|
| Serum Globulins | 1 | 1983 | 23 | 0.000 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1984 | 169 | 0.000 |
Why?
|
| Neuraminic Acids | 2 | 1972 | 16 | 0.000 |
Why?
|
| Pain | 1 | 1998 | 5073 | 0.000 |
Why?
|
| Agglutinins | 1 | 1981 | 28 | 0.000 |
Why?
|
| Complement C3b | 1 | 1982 | 97 | 0.000 |
Why?
|
| Complement C4 | 1 | 1982 | 217 | 0.000 |
Why?
|
| Luminescent Measurements | 1 | 1983 | 342 | 0.000 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1992 | 1469 | 0.000 |
Why?
|
| H-2 Antigens | 1 | 1982 | 357 | 0.000 |
Why?
|
| Chlamydia | 1 | 1981 | 33 | 0.000 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1983 | 662 | 0.000 |
Why?
|
| Child, Preschool | 2 | 1980 | 42232 | 0.000 |
Why?
|
| Injections, Subcutaneous | 2 | 1972 | 681 | 0.000 |
Why?
|
| Staphylococcus | 1 | 1980 | 154 | 0.000 |
Why?
|
| Counterimmunoelectrophoresis | 1 | 1979 | 14 | 0.000 |
Why?
|
| Chloramphenicol | 1 | 1979 | 67 | 0.000 |
Why?
|
| Cecal Diseases | 1 | 1979 | 49 | 0.000 |
Why?
|
| ABO Blood-Group System | 1 | 1981 | 380 | 0.000 |
Why?
|
| Peptococcus | 1 | 1978 | 5 | 0.000 |
Why?
|
| Eubacterium | 1 | 1978 | 23 | 0.000 |
Why?
|
| Fusobacterium | 1 | 1978 | 53 | 0.000 |
Why?
|
| Cellulitis | 1 | 1980 | 209 | 0.000 |
Why?
|
| Barium Sulfate | 1 | 1978 | 180 | 0.000 |
Why?
|
| Texas | 1 | 1979 | 404 | 0.000 |
Why?
|
| Anus Diseases | 1 | 1977 | 55 | 0.000 |
Why?
|
| Gentamicins | 1 | 1978 | 243 | 0.000 |
Why?
|
| Vaginal Diseases | 1 | 1977 | 103 | 0.000 |
Why?
|
| Pharyngeal Diseases | 1 | 1977 | 134 | 0.000 |
Why?
|
| NAD | 1 | 1980 | 614 | 0.000 |
Why?
|
| Intestinal Perforation | 1 | 1978 | 249 | 0.000 |
Why?
|
| Mannose | 1 | 1976 | 121 | 0.000 |
Why?
|
| Parity | 1 | 1979 | 927 | 0.000 |
Why?
|
| Pelvis | 1 | 1980 | 733 | 0.000 |
Why?
|
| Child | 2 | 1980 | 80158 | 0.000 |
Why?
|
| Family Characteristics | 1 | 1979 | 1004 | 0.000 |
Why?
|
| Immune Adherence Reaction | 1 | 1972 | 29 | 0.000 |
Why?
|
| Osteomyelitis | 1 | 1977 | 407 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1972 | 299 | 0.000 |
Why?
|
| Arthritis | 1 | 1977 | 680 | 0.000 |
Why?
|
| Injections, Jet | 1 | 1971 | 8 | 0.000 |
Why?
|
| Erythema | 1 | 1972 | 262 | 0.000 |
Why?
|
| Blood Group Antigens | 1 | 1972 | 184 | 0.000 |
Why?
|
| Isoantigens | 1 | 1972 | 551 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1986 | 5841 | 0.000 |
Why?
|
| Influenza Vaccines | 1 | 1972 | 768 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1979 | 7828 | 0.000 |
Why?
|